Advanced Biomed Inc. (ADVB) - Dilution Analysis

10-Q filing | 1.3M shares outstanding

S-1 filing: This S-1 filing relates to the offer and sale of up to $25,000,000 in shares of Advanced Biomed Inc.'s Common Stock by Helena Global Investment Opportunities I Ltd. pursuant to an equity line of credit agreement, as well as the issuance of Commitment Fee Shares to the Selling Stockholder having an aggregate value of $500,000.

10-Q filing | 20.5M shares outstanding

10-Q filing | 20.0M shares outstanding

8-K filing: Advanced Biomed Inc. completed an initial public offering of 1,640,000 shares of common stock at $4.00 per share on March 7, 2025, and issued warrants to the underwriter to purchase up to 98,400 shares of common stock at $5.00 per share. ($6.56M proceeds)

S-1/A filing: This S-1/A filing, dated February 7, 2025, relates to a primary offering of 1,875,000 shares of common stock by Advanced Biomed Inc., with an expected price range of $4.00 to $6.00 per share, and also registers 1,875,000 shares for resale by selling stockholders.

S-1/A filing: This S-1/A filing, dated January 27, 2025, relates to the offer and sale of 1,875,000 shares of common stock of Advanced Biomed Inc., with an expected Primary Offering price between $4.00 and $6.00 per share, and an additional 1,875,000 shares for resale by selling stockholders.

S-1/A filing: This S-1/A filing, dated January 7, 2025, relates to the offer and sale of 1,875,000 shares of common stock of Advanced Biomed Inc. subject to completion and also registers 1,875,000 shares of common stock for resale by selling stockholders.

S-1/A filing: This is an S-1/A filing for the resale of 1,875,000 shares of common stock by selling shareholders. The company has applied to list its Common Stock on the Nasdaq Capital Market under the symbol 'ADVB'.

S-1/A filing: This prospectus relates to the offer and sale of 25,000,000 shares of common stock, par value $0.001 per share, of Advanced Biomed Inc.

S-1/A filing: This prospectus relates to the offer and sale of 25,000,000 shares of common stock, par value $0.001 per share, of Advanced Biomed Inc.

S-1/A filing: This prospectus relates to the offer and sale of 25,000,000 shares of common stock, par value $0.001 per share, of Advanced Biomed Inc.

S-1/A filing: This prospectus relates to the offer and sale of 25,000,000 shares of common stock of Advanced Biomed Inc.

S-1/A filing: This is an S-1/A filing detailing the costs and expenses associated with the sale of common stock, including SEC registration fees, printing expenses, FINRA filing fees, Nasdaq listing fees, legal and accounting fees, and miscellaneous expenses. It also describes indemnification of directors and officers under Nevada law.

S-1/A filing: This S-1/A filing relates to the offer and sale of 25,000,000 shares of common stock of Advanced Biomed Inc. with an expected IPO price between $4.00 and $5.00 per share.

S-1/A filing: This S-1/A filing outlines the terms of an agreement between Advanced Biomed Inc. and several underwriters, led by Univest Securities, LLC, for the issuance and sale of 25,000,000 shares of common stock, with an option for the underwriters to purchase an additional 3,750,000 shares to cover over-allotments. It also includes warrants to purchase common stock for the representative of the underwriters.

S-1/A filing: This S-1/A filing registers 25,000,000 shares of common stock through an equity line offering with Univest Securities, LLC as the underwriter. Additionally, it includes warrants for the underwriter to purchase 250,000 shares and an option for the underwriters to purchase up to 3,750,000 additional shares to cover over-allotments.

S-1/A filing: This is an S-1/A filing for an initial public offering of 25,000,000 shares of common stock of Advanced Biomed Inc., with an expected price between $4.00 and $5.00 per share.

S-1/A filing: This prospectus relates to the offer and sale of 25,000,000 shares of common stock, par value $0.001 per share, of Advanced Biomed Inc.

S-1/A filing: This prospectus relates to the offer and sale of 25,000,000 shares of common stock, par value $0.001 per share, of Advanced Biomed Inc. We expect that the initial public offering price will be between $4.00 to $5.00 per share of common stock.

S-1/A filing: This is an S-1/A filing for an offering of common stock. The underwriters are obligated to take and pay for all of the shares offered by this prospectus if any such shares are taken.

S-1 filing: This is an S-1 filing for an initial public offering of common stock by Advanced Biomed Inc.